NOSH-aspirin: A novel nitric oxide-hydrogen sulfide-releasing hybrid: A new class of anti-inflammatory pharmaceuticals
from ACS Medicinal Chemistry Letters
Scientists have combined two new "designer" forms of aspirin into a hybrid substance that appears more effective than either of its forebears in controlling the growth of several forms of cancer in laboratory tests. Their report on the new NOSH-aspirin, so named because it releases nitric oxide and hydrogen sulfide, appears in the journal ACS Medicinal Chemistry Letters.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063